Total pharmaceutical sales in Sweden during February–April 2009 were EUR 731 (777) million in pharmacy purchase prices (PPP). In local currency, this represents an increase of 5% compared to the same period in the previous year.
Tamro Sweden’s net sales during February–April were EUR 354 (388) million. In local currency, the sales increased by 7%, mainly due to a new major supply contract. The company’s average market share increased to 55%. Tamro Sweden employed an average of 446 (438) people.
At the end of April, the Swedish Parliament made the formal decision to de-regulate the Swedish pharmacy market as from 1 July 2009 and to sell out 466 state-owned pharmacies.
Tamro is considering entering the Swedish pharmacy market. However, the future structure of Swedish pharmaceutical wholesaling and some other issues such as OTC liberalisation have not yet been determined. Therefore, Tamro has not yet made its decision to participate in the auction process. The auction process is expected to be concluded during the late autumn.
